文献速递卫生政策与健康促进免疫规划

参与者、研究者和媒体在疫苗试验传播中的角色与责任:英国首个COVID-19疫苗试验的经验

Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: Experience from the United Kingdom's first COVID-19 vaccine trial.
PubMed 文献 · Vaccine · 2024-10-01

该研究基于2020年对英国首个牛津-阿斯利康COVID-19疫苗首次人体临床试验的349份调查问卷和102份半结构化访谈的回顾性分析,探讨疫苗试验传播中参与者、研究者和媒体的不同角色与责任。参与者对是否负有传播责任看法不一,部分认为有利他义务,部分认为分享者为博眼球,且倾向匿名;对煽情和虚假报道感到沮丧;社交媒体被视为加速错误信息或促进招募和公众教育的工具;研究者现身媒体增强了对疫苗和试验的信心。作者建议为所有参与者提供与媒体互动的明确全面指南、优先公开试验构成与流程、为记者提供支持与直接沟通渠道。

要点

  • 参与者对是否负有传播试验经历的责任看法不一,部分认为有利他义务,部分认为分享者为博眼球。
  • 参与者倾向于匿名发声,并对煽情和虚假媒体报道感到沮丧。
  • 作者建议为所有参与者提供与媒体互动的明确全面指南,并优先公开试验构成与流程。

核心结论

  • 大流行表明临床试验应作为需要更好公众理解和参与的科学实践而更加透明。
  • 针对高关注度疫苗试验,作者推荐:为所有参与者提供与媒体互动的明确全面指南;优先公开并有效表达试验构成、流程和参与情况;利用内部新闻官为记者提供支持与直接沟通渠道以报道试验。

研究设计与样本

  • 回顾性研究,分析2020年英国首个牛津-阿斯利康COVID-19疫苗首次人体临床试验参与者的349份调查问卷和102份半结构化访谈。

主要发现

  • 参与者对参与是否赋予更广泛传播试验经历的责任看法不一,部分认为有利他义务,部分认为分享者为博眼球。
  • 参与者发声时倾向于匿名,并对煽情和虚假媒体报道感到沮丧。
  • 社交媒体被视为加速错误信息或促进招募和公众教育的工具。
  • 参与者乐见试验研究者和团队在媒体中发挥重要作用,这增强了对疫苗和试验的信心。

临床怎么用

  • 作者建议为所有参与者提供与媒体互动的明确全面指南。
  • 作者建议优先公开并有效表达试验构成、流程和参与情况。
  • 作者建议利用内部新闻官为记者提供支持与直接沟通渠道以报道试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The media have played an important part in presenting arguments for and against vaccination. The potential for the media to influence public attitudes to vaccines is becoming increasingly crucial to address. METHODS: To understand the differing roles and responsibilities in the communication of vaccine trials we draw insight from a retrospective study of 349 survey responses and 102 semi-structured interviews conducted in 2020 with participants in the United Kingdom's first-in-human clinical trial of the Oxford-AstraZeneca COVID-19 vaccine. RESULTS: We found that trial participants had mixed views as to whether their participation conferred responsibility to communicate more widely about their trial experiences. Some participants perceived themselves to have an altruistic obligation to communicate to the media about the trial, and others felt that those who did share their participation had 'attention-seeking' motives. When participants did speak out they preferred to do so anonymously. Frustration was also reported with sensationalised and false media stories. Social media was viewed as a means to accelerate misinformation or as a force for recruitment and public education about trials. Participants were pleased to see trial investigators and trial team playing prominent roles in the media and this instilled confidence in the vaccine and the trial. We discuss these evolving roles and responsibilities for trial communication, concentrating on the views of participants about experiences, opportunities, and risks. CONCLUSIONS: We argue that the pandemic has demonstrated the need for clinical trials to be made more transparent as a scientific practice that requires better public understanding and engagement. For high-profile vaccine trials we recommend; (1) explicit and comprehensive guidance aimed at all participants for interactions with the media; (2) prioritising having open and effectively expressed accounts of trial composition, processes, and participation; (3) offering support and a direct communication channel for journalists to report trials by utilising internal press officers to engage with journalists.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Patrick-Smith M, Emary K, Hodgson SH, et al. Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: Experience from the United Kingdom's first COVID-19 vaccine trial. Vaccine. 2024. PMID: 39357462. doi:10.1016/j.vaccine.2024.126391

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。